Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
NPJ Parkinson'S Disease|January 22, 2021
The impact of COVID-19 and social distancing on people with Parkinson's disease: a survey studyMegan P Feeney, Yaqian Xu, Matthew Surface, et al.
The Science of the Total Environment|June 22, 2023
Novel macromolecular synthetic phenolic antioxidants in sludge on a national scale in China: Their distribution, potential transformation products, and ecological riskYaqian Xu, Yu Hu, Tingting Ding, et al.
Ebiomedicine|September 5, 2021
Predictive and prognostic impact of ferroptosis-related genes ACSL4 and GPX4 on breast cancer treated with neoadjuvant chemotherapyRui Sha, Yaqian Xu, Chenwei Yuan, et al.
Journal of Refractive Surgery (Thorofare, N.J. : 1995)|April 8, 2025
Anterior Segment Characteristics Changes After Implantable Collamer Lens V4c in Low Anterior Chamber Depth Eyes: An Optical Coherence Tomography StudyZhanyu Su, Shanshan Wang, Siya Li, et al.
Epigenomics|November 13, 2018
Identification and integrated analysis of key differentially expressed circular RNAs in ER-positive subtype breast cancerChenwei Yuan, Liheng Zhou, Lei Zhang, et al.
International Journal of Molecular Sciences|December 10, 2021
Dexmedetomidine Promotes Lipopolysaccharide-Induced Differentiation of Cardiac Fibroblasts and Collagen I/III Synthesis through α<sub>2A</sub> Adrenoreceptor-Mediated Activation of the PKC-p38-Smad2/3 Signaling Pathway in MiceJia Liao, Kaiying Li, Xingyu Su, et al.
European Journal of Medical Research|September 11, 2024
Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohortChenwei Yuan, Yaqian Xu, Liheng Zhou, et al.
Therapeutic Advances in Medical Oncology|August 13, 2020
Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapyYaqian Xu, Yan Wang, Chenwei Yuan, et al.
Cell Death & Disease|October 23, 2020
TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancerShan Zhang, Peiqi Huang, Huijuan Dai, et al.
Frontiers in Oncology|October 20, 2022
Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancerZihan Wang, Wei Xu, Yanlian Yang, et al.
Pageof 8